Stock listing

NASDAQ:DCPH Deciphera Pharmaceuticals LLC Stock

Follow Deciphera Pharmaceuticals LLC into a list and get an email when it puts out news.

Last close · NASDAQ:DCPH

$25.59 USD

Close on Jun 10, 2024 · No longer trades

Dec 8, 2016 to last close +593.5% · weekly closes, Dec 8, 2016 – Jun 10, 2024
Lowest – highest close
$3.62 – $86.04 USDSince Dec 8, 2016 · lowest Dec 14, 2016 · highest Sep 1, 2017

Delisted NASDAQ:DCPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:DCPH
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Deciphera Pharmaceuticals LLC on 6ix

Decks
3 decks · latest Nov 12, 2020

Decks

DeckKindSlidesDate
CTOS Annual Meeting 2020Conference14 slidesNov 12, 2020
Investor Presentation (January 2020)Investor deck35 slidesJan 13, 2020
Technical Presentation (September 2019)Technical18 slidesSep 30, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ron Squarer
Other companies: Nuvalent, Inc. (Director · Since at least Dec 10, 2025); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Travere Therapeutics, Inc. (Director · Since at least May 14, 2021)
Director · Jan 15, 2021 – Jun 11, 2024 · Past
James Bristol
Other companies: Erasca, Inc. (Board Director · Since at least Jan 1, 2024); Ernexa Therapeutics Inc. (Chairman · Since at least Oct 30, 2023)
Director · Jun 11, 2024 – Jun 11, 2024 · Past
Dashyant Dhanak
Other companies: Incyte Corporation (EVP & Chief Scientific Officer · Dec 10, 2018 – Jul 14, 2023 · Past)
EVP & Chief Scientific Officer · Sep 5, 2023 – Jun 11, 2024 · Past
Edward J Benz Jr
Other companies: Candel Therapeutics, Inc. (Director · Since at least Jun 26, 2024)
Director · Jun 11, 2024 – Jun 11, 2024 · Past
Matthew L Sherman
Other companies: Palvella Therapeutics, Inc. (Director · Jun 25, 2021 – Jun 21, 2023 · Past)
EVP & Chief Medical Officer · Oct 2, 2020 – Jun 11, 2024 · Past
Thomas Patrick Kelly
Other companies: Xenon Pharmaceuticals Inc. (Chief Financial Officer · Since at least Oct 15, 2025)
Chief Financial Officer · May 1, 2019 – Jun 11, 2024 · Past
Daniel C MartinChief Commercial Officer · Sep 18, 2018 – Jun 11, 2024 · Past
Daniel Lee FlynnChief Scientific Officer · Sep 27, 2017 – Jun 16, 2023 · Past
Dennis Leo WalshDirector · Sep 27, 2017 – Jun 11, 2024 · Past
Franklin Stuart FriedmanDirector · Nov 25, 2019 – Jun 11, 2024 · Past
All 11 people
PersonSeat
Oliver RosenChief Medical Officer · Sep 27, 2017 – Oct 2, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Deciphera Pharmaceuticals LLC.